Advertisement

A Genetic Analysis for Patients with Pulmonary Arterial Hypertension

  • Yu Yoshida
  • Keiko Uchida
  • Kazuki Kodo
  • Yoshiyuki Furutani
  • Toshio Nakanishi
  • Hiroyuki YamagishiEmail author
Open Access
Conference paper
  • 531 Downloads

Abstract

Pulmonary arterial hypertension (PAH) is a lethal disease [1]. Although mutations in BMPR2 and other genes have been reported, the genetic causes in large numbers of patients, especially with sporadic PAH, remain unknown. In 2013, Kerstjens-Frederikse et al. first reported TBX4 mutations in patients with PAH [2]. TBX4 is an essential transcription factor for the development of the hindlimbs and lungs [3]. In European countries, the frequency of TBX4 mutation was reported as 2.4–4.1% in adult-onset PAH [2, 4] and as 7.5–30% in child-onset PAH [2, 5] (Fig. 27.1). However, its frequency in Asian patients with PAH has yet to be studied.

Keywords

T-box TBX4 Pulmonary hypertension Genetic analysis 
Pulmonary arterial hypertension (PAH) is a lethal disease [1]. Although mutations in BMPR2 and other genes have been reported, the genetic causes in large numbers of patients, especially with sporadic PAH, remain unknown. In 2013, Kerstjens-Frederikse et al. first reported TBX4 mutations in patients with PAH [2]. TBX4 is an essential transcription factor for the development of the hindlimbs and lungs [3]. In European countries, the frequency of TBX4 mutation was reported as 2.4–4.1% in adult-onset PAH [2, 4] and as 7.5–30% in child-onset PAH [2, 5] (Fig. 27.1). However, its frequency in Asian patients with PAH has yet to be studied.
Fig. 27.1

Summary of the position of the previously reported variants in TBX4. Upper labels indicate variants with child-onset PAH; lower labels indicate variants with adult-onset PAH. NLS nuclear localization signal

In our genetic analysis for patients with PAH, at least nine sequence variants in exons and six sequence variants in flanking introns of TBX4 were found. The allele frequencies of variants in the Japanese population are under investigation. The detected variants will be validated using the following web databases: UCSC genome browser (https://genome-asia.ucsc.edu), Ensembl (http://www.ensembl.org), PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2), SIFT (http://sift.jcvi.org), Human Splicing Finder (http://umd.be/HSF3), and Protein Data Bank Japan (https://pdbj.org) for their functional significance. We are further attempting to establish the experimental system of functional analysis for the identified variants of TBX4 using cell culture with luciferase, immunoprecipitation, and immunohistochemistry assays in order to elucidate the molecular mechanism underlying PAH resulting from TBX4 mutations.

This study suggests that TBX4 may be a prevalent genetic cause of PAH not only in Caucasians but also within Japanese/Asian populations. Our ongoing studies would soon reveal the functional relevance and genotype–phenotype correlations in patients with PAH associated with TBX4 mutations.

References

  1. 1.
    Chin K, Torres F, Rubin LJ. Idiopathic and heritable pulmonary hypertension: introduction to pathophysiology and clinical aspects. In: Peacock AJ, Naeije R, Rubin LJ, editors. Pulmonary circulation: diseases and their treatment. 3rd ed. London: Hodder Arnold; 2012. p. 207–11.Google Scholar
  2. 2.
    Kerstjens-Frederikse WS, Bongers EM, Roofthooft MT, et al. TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. J Med Genet. 2013;50:500–6.CrossRefGoogle Scholar
  3. 3.
    Papaioannou VE. The T-box gene family: emerging roles in development, stem cells and cancer. Development. 2014;141:3819–33.CrossRefGoogle Scholar
  4. 4.
    Navas P, Tenorio J, Quezada CA, et al. Molecular analysis of BMPR2, TBX4, and KCNK3 and genotype-phenotype correlations in Spanish patients and families with idiopathic and hereditary pulmonary arterial hypertension. Rev Esp Cardiol. 2016;69:1011–9.CrossRefGoogle Scholar
  5. 5.
    Levy M, Eyries M, Szezepanski I, et al. Genetic analyses in a cohort of children with pulmonary hypertension. Eur Respir J. 2016;48:1118–26.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2020

Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  • Yu Yoshida
    • 1
  • Keiko Uchida
    • 1
  • Kazuki Kodo
    • 1
  • Yoshiyuki Furutani
    • 2
  • Toshio Nakanishi
    • 2
  • Hiroyuki Yamagishi
    • 3
    Email author
  1. 1.Department of PediatricsKeio University School of MedicineTokyoJapan
  2. 2.Department of Pediatric CardiologyTokyo Women’s Medical UniversityTokyoJapan
  3. 3.Division of Pediatric Cardiology, Department of PediatricsKeio University School of MedicineTokyoJapan

Personalised recommendations